Vitamin D, 1,25-Dihydroxy (Vit D 1-25-DOH)
Order Name
VIT D1-25
Test Number: 3603730
Revision Date 10/20/2018
Test Number: 3603730
Revision Date 10/20/2018
Test Name | Methodology | LOINC Code |
---|---|---|
Vitamin D, 1,25-Dihydroxy (Vit D 1-25-DOH)
|
Quantitative Chemiluminescent Immunoassay | 62290-2 |
SPECIMEN REQUIREMENTS | ||||
---|---|---|---|---|
Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
Preferred | 1mL (0.5) | Serum | Clot Activator (Red Top, No-Gel) | Refrigerated or Frozen |
Alternate 1 | 1mL (0.5) | Serum | Clot Activator SST | Refrigerated or Frozen |
Alternate 2 | 1mL (0.5) | Plasma | EDTA (Lavender Top) | Refrigerated or Frozen |
Instructions | Allow serum separator or plain red tube to sit for 15-20 minutes at room temperature for proper clot formation. Centrifuge and separate serum or plasma from cells ASAP or within 2 hours of collection. Transport Refrigerated or Frozen in plastic aliquot tube. Stability After separation from cells: Ambient: 72 hours; Refrigerated 1 week; Frozen 6 months. |
GENERAL INFORMATION | |
---|---|
Testing Schedule | Mon, Wed, Fri |
Expected TAT | 3-5 Days |
Clinical Use | Vitamin D originating from dietary and endogenous sources is converted to 25-hydroxyvitamin D in the liver, and subsequently to 1-25 Dihydroxy vitamin D in the kidney. Deficiencies of 1-25 Dihydroxy vitamin D, the most active form, cause hypocalcemia, osteomalacia, and related disorders. Measurement is useful in: differentiating primary hyperparathyroidism from hypercalcemia of cancer; distinguishing between vitamin D dependent and vitamin D resistant rickets; monitoring vitamin D status of patients with chronic renal disease; and, assessing compliance to therapy. |
Notes | This test is used to measure the bio-active form of Vitamin D. This test is also used in the differential diagnosis of hypocalcemia and to monitor patients with renal osteodystrophy or chronic renal failure. |
CPT Code(s) | 82652 |
Lab Section | Immunology - Serology |